Patents by Inventor Robert E. Hurst

Robert E. Hurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8101159
    Abstract: In vitro and in vivo methods for identifying compounds capable of targeting suppressed cancer cells such as micrometastatic cells. The in vitro method includes the steps of comparing the response to a test compound of cancer cells grown on a suppressing cell support matrix which causes suppression of a malignant phenotype in a growing cancer cell and on a non-suppressing cell support matrix. The in vivo method includes a step of co-injecting labeled cancer cells with a malignant-phenotype suppressing matrix into a test animal to produce suppressed micrometastatic cells therein.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: January 24, 2012
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Robert E. Hurst, Michael A. Ihnat
  • Publication number: 20090311188
    Abstract: In vitro and in vivo methods for identifying compounds capable of targeting suppressed cancer cells such as micrometastatic cells. The in vitro method includes the steps of comparing the response to a test compound of cancer cells grown on a suppressing cell support matrix which causes suppression of a malignant phenotype in a growing cancer cell and on a non-suppressing cell support matrix. The in vivo method includes a step of co-injecting labeled cancer cells with a malignant-phenotype suppressing matrix into a test animal to produce suppressed micrometastatic cells therein.
    Type: Application
    Filed: August 13, 2009
    Publication date: December 17, 2009
    Inventors: Robert E. Hurst, Michael A. Ihnat
  • Patent number: 7575926
    Abstract: A method for identifying compounds capable of targeting suppressed cancer cells, the method including the steps of comparing the response to a test compound of cancer cells grown on a suppressing cell support matrix which causes suppression of a malignant phenotype in a growing cancer cell and on a non-suppressing cell support matrix.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: August 18, 2009
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Robert E. Hurst, Michael A. Ihnat, Kimberly D. Kyker
  • Patent number: 6372450
    Abstract: A composition and treatment method for fixating cells and for preparing them for examination. In particular, the invention contemplates compositions effective in inhibiting crystal formation in the cell sample and effective in enhancing cell adherence to examination slides.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: April 16, 2002
    Assignee: Southpac Trust Int'l. Inc.
    Inventors: George P. Hemstreet, III, Robert E. Hurst, Rebecca B. Bonner
  • Patent number: 6194165
    Abstract: A composition and treatment method for fixating cells and for preparing them for examination. In particular, the invention contemplates compositions effective in inhibiting crystal formation in the cell sample and effective in enhancing cell adherence to examination slides.
    Type: Grant
    Filed: October 2, 1998
    Date of Patent: February 27, 2001
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: George P. Hemstreet, III, Robert E. Hurst, Rebecca B. Bonner
  • Patent number: 5997519
    Abstract: A fluid collection device having a primary container and a secondary container and a two stage fixation system for facilitating and controlling the fixation of cells in a sample of a biological fluid such as urine. The primary container generally comprises a plastic cup having a filtering apparatus disposed within it for filtering cells from the fluid. The primary container may contain a first stage fixative. The device further comprises a cover comprising a pressurizing chamber for forcing fluid through the filter and fixative delivery chamber for dispensing a fixative into the primary container. The filtered fluid may be reserved within a secondary container attached to the primary container. The filter having the cells retained on its surface is removable from the primary container for the purpose of laboratory analyses of the cells.
    Type: Grant
    Filed: April 6, 1998
    Date of Patent: December 7, 1999
    Assignee: The Board of Regents of The University of Oklahoma
    Inventors: George P. Hemstreet, Karl H. Bergey, Robert E. Hurst, Rebecca B. Bonner
  • Patent number: 5824495
    Abstract: A composition and treatment method for fixation cells and for preparing them for examination. In particular, the invention contemplates compositions effective in inhibiting crystal formation in the cell sample and effective in enhancing cell adherence to examination slides.
    Type: Grant
    Filed: March 20, 1997
    Date of Patent: October 20, 1998
    Assignee: Southpac Trust International, Inc.
    Inventors: George P. Hemstreet, III, Robert E. Hurst, Rebecca B. Bonner
  • Patent number: 5741648
    Abstract: A system for evaluating one or more biochemical markers for evaluating individual cancer risk, cancer diagnosis and for monitoring therapeutic effectiveness and cancer recurrence, particularly of bladder cancer. The system uses automated quantitative fluorescence image analysis of a cell sample collected from a body organ. Cells are treated with a fixative solution which inhibits crystal formation. Cell images are selected and stored as grey level images for further analysis. Cell images may be corrected for autofluorescence using a novel autofluorescence correction method. A neural net computer may be used to distinguish true-positive images from false-positive images to improve accuracy of cancer risk assessment. Cells having images positive for a marker amy be compared to threshold quantities related to predetermined cancer risk.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: April 21, 1998
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: George P. Hemstreet, III, Robert E. Hurst, Rebecca B. Bonner, Jian Yu Rao
  • Patent number: 5735834
    Abstract: A fluid collection device having a primary container and a secondary container and a two stage fixation system for facilitating and controlling the fixation of cells in a sample of a biological fluid such as urine. The primary container generally comprises a plastic cup having a filtering apparatus disposed within it for filtering cells from the fluid. The primary container may contain a first stage fixative. The device further comprises a cover comprising a pressurizing chamber for forcing fluid through the filter and fixative delivery chamber for dispensing a fixative into the primary container. The filtered fluid may be reserved within a secondary container attached to the primary container. The filter having the cells retained on its surface is removable from the primary container for the purpose of laboratory analyses of the cells.
    Type: Grant
    Filed: December 17, 1996
    Date of Patent: April 7, 1998
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: George P. Hemstreet, Karl H. Bergey, Robert E. Hurst, Rebecca B. Bonner
  • Patent number: 5733721
    Abstract: A system for evaluating one or more biochemical markers for evaluating individual cancer risk, cancer diagnosis and for monitoring therapeutic effectiveness and cancer recurrence, particularly of bladder cancer. The system uses automated quantitative fluorescence image analysis of a cell sample collected from a body organ. Cells are treated with a fixative solution which inhibits crystal formation. Cell images are selected and stored as grey level images for further analysis. Cell images may be corrected for autofluorescence using a novel autofluorescence correction method. A neural net computer may be used to distinguish true-positive images from false-positive images to improve accuracy of cancer risk assessment. Cells having images positive for a marker amy be compared to threshold quantities related to predetermined cancer risk.
    Type: Grant
    Filed: December 20, 1992
    Date of Patent: March 31, 1998
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: George P. Hemstreet, III, Robert E. Hurst, Rebecca B. Bonner, Jian Yu Rao
  • Patent number: 5599331
    Abstract: A fluid collection device having a primary container and a secondary container and a two stage fixation system for facilitating and controlling the fixation of cells in a sample of a biological fluid such as urine. The primary container generally comprises a plastic cup having a filtering apparatus disposed within it for filtering cells from the fluid. The primary container may contain a first stage fixative. The device further comprises a cover comprising a pressurizing chamber for forcing fluid through the filter and fixative delivery chamber for dispensing a fixative into the primary container. The filtered fluid may be reserved within a secondary container attached to the primary container. The filter having the cells retained on its surface is removable from the primary container for the purpose of laboratory analyses of the cells.
    Type: Grant
    Filed: January 9, 1995
    Date of Patent: February 4, 1997
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: George P. Hemstreet, Karl H. Bergey, Robert E. Hurst, Rebecca B. Bonner
  • Patent number: 5380289
    Abstract: A fluid collection device having a primary container and a secondary container and a two stage fixation system for facilitating and controlling the fixation of cells in a sample of a biological fluid such as urine. The primary container generally comprises a plastic cup having a filtering apparatus disposed within it for filtering cells from the fluid. The primary container may contain a first stage fixative. The device further comprises a cover comprising a pressurizing chamber for forcing fluid through the filter and fixative delivery chamber for dispensing a fixative into the primary container. The filtered fluid may be reserved within a secondary container attached to the primary container. The filter having the cells retained on its surface is removable from the primary container for the purpose of laboratory analyses of the cells.
    Type: Grant
    Filed: January 19, 1993
    Date of Patent: January 10, 1995
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: George P. Hemstreet, Karl H. Bergey, Robert E. Hurst, Rebecca B. Bonner
  • Patent number: 4044563
    Abstract: A method is provided for filling a subterranean void, e.g. a mined out cavity such as a tunnel. An aqueous suspension of solid particles the mass of which when at rest has a permeability of about 40 darcies, preferably less than 20 darcies, is injected into the void to effect complete filling.
    Type: Grant
    Filed: January 26, 1973
    Date of Patent: August 30, 1977
    Assignee: The Dow Chemical Company
    Inventors: Robert E. Hurst, Charles L. Lunsford